Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

NCT06231381 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Pustular Psoriasis (GPP)

Interventions

DRUG: HB0034
OTHER: Placebo

Sponsor

Shanghai Huaota Biopharmaceutical Co., Ltd.